Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

02 juin 2015 08h00 HE | Source: Chinook Therapeutics, Inc.

Aduro Biotech Appoints Liana Wu as Vice President of Commercial

BERKELEY, Calif., June 2, 2015 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (Nasdaq:ADRO) today announced that Liana Wu has joined the company as vice president, commercial. Ms. Wu, a commercial leader...
01 juin 2015 09h00 HE | Source: Chinook Therapeutics, Inc.

Aduro Biotech Announces ASCO Presentation of Encouraging Data From Ongoing Phase 1b Clinical Trial of Its Immunotherapy for the Treatment of Mesothelioma

BERKELEY, Calif., June 1, 2015 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (Nasdaq:ADRO) today announced the presentation of interim safety and efficacy data from an ongoing Phase 1b clinical trial of its...
28 mai 2015 16h00 HE | Source: Chinook Therapeutics, Inc.

Aduro Biotech Announces First Quarter 2015 Financial Results

Established major $750M collaboration with Novartis for STING in oncology Strengthened cash position with $200M upfront payment from Novartis and $149.3M in net proceeds from IPO and...